Burkhart Erin 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 20, 2025
Insider Transaction Report
Form 4
Burkhart Erin
GVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-03-19$71.52/sh−1,295$92,618→ 16,955 total
Footnotes (2)
- [F1]Trade made pursuant to a 10b5-1 plan executed on November 26, 2024.
- [F2]The Reporting Person's direct holdings have been adjusted by two shares to correct a previous clerical error.